Cell-based Assays Market 2015 by Product, Applications, End User, & Region - Global Forecast to 2020

DUBLIN, December 2, 2015 /PRNewswire/ --

Research and Markets (http://www.researchandmarkets.com/research/c4bcq7/cellbased_assays) has announced the addition of the "Cell-based Assays Market by Product, Applications, End User, & Region - Global Forecast to 2020" report to their offering. 

     (Logo: http://photos.prnewswire.com/prnh/20130307/600769 )

The global cell-based assays market is expected to reach USD 18,329.37 Million by 2020 from USD 10,799.53 Million in 2015, growing at a CAGR of 11.16% between 2015 and 2020. Cell-based assays market refers to a wide range of sensitive and reliable methods for research studies on live cells for basic research-based and commercial applications used in pharmaceutical & biotechnology companies, academic & government institutions and contract research organizations. Increasing R&D spending and advancements in cell-based assay techniques will drive the growth of the market. 

This report segments the global cell-based assays market by products, applications and end users. The global market product segments included in the report comprises of consumables, instruments, services and software. The cconsumables segment is further divided on the basis of type into reagents & assay kits, microplates and cell lines. Reagents & assay kits segment is further divided into reporter gene assays, second messenger assays, cell growth assays, cell death assays and other assays. Cell lines segment is further classified into immortalized cell lines, primary cell lines and stem cell lines. 

The applications included in this report are drug discovery, basic research, predictive toxicology, ADME studies and other applications. The drug discovery had the largest share of the cell-based assays market in 2015. Predictive toxicology is expected to one of the fastest growing applications between 2015 and 2020. 

On the basis of end users the global cell-based assays market report is segmented into pharmaceutical and biotechnology companies, academic institutions, CROs and other end users. The geographic segments included in this report are North America, Europe, Asia and Rest of the World (RoW). The geographic analysis reveals that North America accounted for the largest share in the global market in 2015. Asia regional segment, on the other hand, is expected to register a faster growth from 2015 to 2020, due to the large number of CROs that offer drug discovery services to serve pharmaceutical and biotechnology companies which ultimately drives cell-based assays market. 

The major players in cell-based assays market include Becton, Dickinson and Company (U.S.), Merck & Co, Inc. (U.S.), Danaher Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), PerkinElmer, Inc. (U.S.), Cell Signaling Technology, Inc. (U.S.), Cisbio Bioassays (France), DiscoveRx (U.S.), General Electric Company (U.S.), and Promega Corporation (U.S.). 

Key Topics Covered: 

1. Introduction

2. Research Methodology

3. Executive Summary

4. Premium Insights

5. Market Overview

6. Cell-Based Assays Market, by Product

7. Cell-Based Assays Market, by Application

8. Cell-Based Assays Market, by End User

9. Cell-Based Assays Market, by Region

10. Competitive Landscape

11. Company Profiles 

- Becton, Dickinson and Company 
- Cell Signaling Technology, Inc. 
- Cisbio Bioassays 
- Danaher Corporation 
- Discoverx Corporation 
- General Electric Company 
- Merck & Co., Inc. 
- Perkinelmer, Inc. 
- Promega Corporation 
- Thermo Fisher Scientific, Inc. 

For more information visit http://www.researchandmarkets.com/research/c4bcq7/cellbased_assays

About Research and Markets:

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact: 
Laura Wood
+353-1-481-1716
press@researchandmarkets.net

SOURCE Research and Markets